The Next Decade of Cell and Gene Therapies
May 7, 2025
Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems, and more; we ask experts about the future of advanced medicine.
5 min read
Biopharma
Biotech Versus the Superbugs
April 7, 2025
Meet one company and its new drug candidate in the fight against gram-negative bacterial infections.
6 min read
Meet the Goldilocks Molecules
March 12, 2025
We get the story behind the development of Spiroligomer molecules and how they can help drug the undruggable.
4 min read
Sitting Down With... Moncef Slaoui
March 3, 2025
From the GSK boardroom to the White House, and now the board of Abzena, the career path of Moncef Slaoui has resulted in billions of doses of lifesaving vaccines. Here he shares his story.
5 min read
AI Approach to Transdermal GLP-1s
February 25, 2025
How do you design, refine, and optimize novel GLP-1 drugs that could improve patient experiences? With a computer, of course.
3 min read
Irish Horizons: Sitting Down With BMS’ Karen Costello
February 17, 2025
Following a spell at Bristol Myers Squibb’s New Jersey facility, General Manager for the Irish commercial affiliate, Karen Costello, returns to her native country to help get medicines to Irish patients faster.
4 min read
The Era of Antibody 2.0
February 14, 2025
Experts look at trends in antibody drug development, including the growing popularity of new modalities.
2 min read
Vial Wars
By Stephanie Vine
February 10, 2025
Study investigates why vial choices matters for frozen biopharmaceutical storage
2 min read
Sanofi’s Push for Pricing Flexibility in the UK
February 7, 2025
We speak with Sanofi about its appeal against NICE’s final draft guidance for Sarclisa.
6 min read
Celebrating the Potential of Biosimilars
By Josh Gissing
February 5, 2025
A look at how biosimilars can increase patient access to essential medicines, as well as improve performance in national and international healthcare systems.
3 min read
